ChemoCentryx (CCXI) Tops Q4 EPS by 2c

ChemoCentryx (NASDAQ: CCXI) reported Q4 EPS of ($0.26), $0.02 better than the analyst estimate of ($0.28).

For earnings history and earnings-related data on ChemoCentryx (CCXI) click here.

You May Also Be Interested In

• Are we witnessing a fundamental or speculative rally in the S&P 500?
• C3.ai (AI) Tops Q4 EPS by 5c, Beats on Revenue; Offers FY27 Revenue Guidance
• Petco Health and Wellness (WOOF) Misses Q1 EPS by 6c